Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TRPM8 antagonist 2 是有效的 RPM8选择性 T 拮抗剂,IC50值为 0.2 nM,在神经性疼痛综合症中有研究价值。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 301 | 现货 | ||
5 mg | ¥ 747 | 现货 | ||
10 mg | ¥ 1,230 | 现货 | ||
25 mg | ¥ 2,190 | 现货 | ||
50 mg | ¥ 3,490 | 现货 | ||
100 mg | ¥ 5,120 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 822 | 现货 |
产品描述 | TRPM8 antagonist 2 is a potent and selective TRPM8 antagonist with an IC50 of 0.2 nM. TRPM8 antagonist 2 is used in the research of neuropathic pain syndromes. |
靶点活性 | TRPM8:0.2 nM |
体外活性 | TRPM8 antagonist 2 (Compound 14) is a potent and selective TRPM8 antagonist, with an IC50 of 0.2 nM, used in the research of neuropathic pain syndromes. TRPM8 antagonist 2 potently inhibits menthol-induced increase in intracellular Ca2+ levels in Ca2+ fluorimetric assays in HEK293 cells stably expressing the rat isoform of TRPM8 channels (IC50, 40 nM). |
体内活性 | TRPM8 antagonist 2 (1, 10, and 30 mg/kg, s.c.) exhibits a marked, dose-dependent antinociceptive activity, and inhibits wet-dog shakes (WDS)-like cold hypersensitivity in mice by 63% at 30 mg/kg. Moreover, TRPM8 antagonist 2 (0.1 and 1 μg, s.c.) attenuates Oxaliplatin (OXP)-induced cold allodynia in mice. |
分子量 | 398.5 |
分子式 | C26H26N2O2 |
CAS No. | 259674-19-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 160 mg/mL (401.51 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5094 mL | 12.5471 mL | 25.0941 mL | 62.7353 mL |
5 mM | 0.5019 mL | 2.5094 mL | 5.0188 mL | 12.5471 mL | |
10 mM | 0.2509 mL | 1.2547 mL | 2.5094 mL | 6.2735 mL | |
20 mM | 0.1255 mL | 0.6274 mL | 1.2547 mL | 3.1368 mL | |
50 mM | 0.0502 mL | 0.2509 mL | 0.5019 mL | 1.2547 mL | |
100 mM | 0.0251 mL | 0.1255 mL | 0.2509 mL | 0.6274 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
TRPM8 antagonist 2 259674-19-6 Membrane transporter/Ion channel TRP/TRPV Channel inhibit Transient receptor potential channels TRP Channel Inhibitor TRPM-8 antagonist 2 inhibitor